MarketCap
Facebook
X
TelegramAnnual report 2023
added 02-29-2024
PetIQ EV - Enterprise Value 2011-2026 | PETQ
Annual EV - Enterprise Value PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 280 M | 295 M | 562 M | 445 M | 1.01 B | 611 M | 321 M | 39.6 M | 42.8 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 B | 39.6 M | 401 M |
EV - Enterprise Value of other stocks in the Drug manufacturers industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
459 M | $ 1.26 | -1.94 % | $ 136 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
23.6 M | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
3.84 B | $ 2.67 | 0.57 % | $ 1.42 B | Canada |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
3.37 M | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
10.2 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
284 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
1.2 B | $ 13.18 | -1.35 % | $ 675 M | USA |
 |
Evoke Pharma
EVOK
|
7.15 M | - | - | $ 36.6 M | USA |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | $ 21.49 | 0.05 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
1.03 B | $ 5.5 | -4.12 % | $ 341 M | USA |
 |
Harrow Health
HROW
|
515 M | $ 49.05 | -3.9 % | $ 1.6 B | USA |
 |
China Pharma Holdings
CPHI
|
11.1 M | $ 1.31 | -3.32 % | $ 22.9 M |  China |
 |
Jupiter Wellness
JUPW
|
91.9 M | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
456 M | $ 1.72 | -0.41 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
392 M | $ 4.18 | -0.83 % | $ 550 M | USA |
 |
Bausch Health Companies
BHC
|
29.9 B | $ 7.79 | 0.13 % | $ 2.84 B | Canada |
 |
Lannett Company
LCI
|
648 M | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
-2.47 M | $ 1.64 | 0.01 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
7.57 M | $ 3.77 | -0.28 % | $ 4.68 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
124 M | $ 4.77 | -1.24 % | $ 67.1 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-110 M | - | - | $ 193 M | Canada |
 |
Tilray
TLRY
|
1.96 B | $ 9.42 | 3.14 % | $ 5.82 B | Canada |
 |
Aurora Cannabis
ACB
|
106 M | $ 4.3 | 0.59 % | $ 86.3 M | Canada |
 |
Veru
VERU
|
111 M | $ 2.39 | 3.46 % | $ 322 M | USA |
 |
Pacira BioSciences
PCRX
|
1.68 B | $ 22.6 | -13.16 % | $ 1.05 B | USA |
 |
cbdMD
YCBD
|
7.85 M | $ 1.04 | -3.7 % | $ 4.49 M | USA |
 |
Perrigo Company plc
PRGO
|
8.73 B | $ 14.85 | 0.99 % | $ 2.04 B | USA |
 |
ProPhase Labs
PRPH
|
145 M | - | - | $ 5.07 M | USA |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
Radius Health
RDUS
|
700 M | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
57.3 M | $ 0.96 | -2.11 % | $ 22.4 M | USA |
 |
Relmada Therapeutics
RLMD
|
170 M | $ 4.41 | -0.45 % | $ 133 M | USA |
 |
OptiNose
OPTN
|
312 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
141 M | $ 9.25 | -0.64 % | $ 657 M | USA |
 |
PLx Pharma
PLXP
|
73.8 M | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
197 M | $ 5.37 | 1.13 % | $ 219 M | USA |
 |
SCYNEXIS
SCYX
|
91.7 M | $ 0.66 | -0.66 % | $ 31.6 M | USA |
 |
Tricida
TCDA
|
506 M | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
33.6 M | $ 2.03 | -1.46 % | $ 21.2 M | USA |
 |
Viatris
VTRS
|
41.3 B | $ 12.66 | 0.46 % | $ 15.3 B | USA |
 |
Zomedica Corp.
ZOM
|
137 M | - | -0.21 % | $ 98 M | USA |